Anti-SARS-CoV-2 Vaccination Campaign: Risk Perception, Emotional States, and Vaccine Hesitancy in a Sample of Adolescents' Vaccinated Parents in Southern Italy.

adolescents’ parents anti-SARS-CoV-2 vaccination emotional states risk perception vaccine hesitancy

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
16 Jun 2022
Historique:
received: 01 05 2022
revised: 13 06 2022
accepted: 14 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

The international strategic plan for COVID-19 vaccines remains the practical option for the protection of health. However, vaccine hesitancy remains an obstacle to full population vaccination, with rapid developments in COVID-19 vaccines and concerns about efficacy acting as influencing factors. The present study investigated the perception of vaccine hesitancy among parents of adolescents in order to explore the reasons and related emotional states. In January-March 2022, an online questionnaire was administered to a sample of parents who brought their children to the vaccine center of a local health unit, ASL Salerno (Campania, Italy). The participants were 1105 parents (F = 64.6%; mean age = 47.37 years, SD = 7.52) of adolescents (F = 47.6%; mean age = 14.83 years, SD = 1.72). All parents had received the COVID-19 vaccine. Regarding the vaccination schedule, 46.8% believed that children receive more vaccinations than they should; 25.1% believed that it is better to develop immunity rather than get vaccinated; 41.2% believed that their child could have side effects; 29.6% were very concerned that vaccines were unsafe, while 35.3% believed vaccines do not prevent disease; 21.5% were very reluctant about pediatric vaccines; and 23.8% did not trust the information received. In order to increase vaccination and reduce the prevalence of vaccine hesitancy, it is essential to support the value of vaccination among all parents and make information more accessible and usable through competent pediatricians.

Sections du résumé

BACKGROUND BACKGROUND
The international strategic plan for COVID-19 vaccines remains the practical option for the protection of health. However, vaccine hesitancy remains an obstacle to full population vaccination, with rapid developments in COVID-19 vaccines and concerns about efficacy acting as influencing factors.
AIM OBJECTIVE
The present study investigated the perception of vaccine hesitancy among parents of adolescents in order to explore the reasons and related emotional states.
METHODS METHODS
In January-March 2022, an online questionnaire was administered to a sample of parents who brought their children to the vaccine center of a local health unit, ASL Salerno (Campania, Italy).
RESULTS RESULTS
The participants were 1105 parents (F = 64.6%; mean age = 47.37 years, SD = 7.52) of adolescents (F = 47.6%; mean age = 14.83 years, SD = 1.72). All parents had received the COVID-19 vaccine. Regarding the vaccination schedule, 46.8% believed that children receive more vaccinations than they should; 25.1% believed that it is better to develop immunity rather than get vaccinated; 41.2% believed that their child could have side effects; 29.6% were very concerned that vaccines were unsafe, while 35.3% believed vaccines do not prevent disease; 21.5% were very reluctant about pediatric vaccines; and 23.8% did not trust the information received.
CONCLUSIONS CONCLUSIONS
In order to increase vaccination and reduce the prevalence of vaccine hesitancy, it is essential to support the value of vaccination among all parents and make information more accessible and usable through competent pediatricians.

Identifiants

pubmed: 35746568
pii: vaccines10060958
doi: 10.3390/vaccines10060958
pmc: PMC9227385
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

PLoS One. 2020 Jun 23;15(6):e0235112
pubmed: 32574184
Int J Environ Res Public Health. 2022 Mar 03;19(5):
pubmed: 35270662
Expert Rev Vaccines. 2022 Apr;21(4):541-547
pubmed: 34949136
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccines (Basel). 2021 Apr 10;9(4):
pubmed: 33920109
Hum Vaccin. 2011 Apr;7(4):419-25
pubmed: 21389777
Health Promot Pract. 2021 Sep;22(5):611-615
pubmed: 33966471
Hum Vaccin Immunother. 2021 Oct 3;17(10):3355-3364
pubmed: 34187310
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Vaccines (Basel). 2022 Mar 04;10(3):
pubmed: 35335028
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317
pubmed: 33828623
J Gen Intern Med. 2021 Oct;36(10):3088-3095
pubmed: 34378115
Ann Ist Super Sanita. 2017 Apr-Jun;53(2):157-162
pubmed: 28617263
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Int J Environ Res Public Health. 2021 Oct 16;18(20):
pubmed: 34682618
BMJ. 2021 Jan 18;372:n120
pubmed: 33461962
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Vaccines (Basel). 2021 Sep 30;9(10):
pubmed: 34696223
Vaccines (Basel). 2021 Jun 07;9(6):
pubmed: 34200347
Int J Environ Res Public Health. 2021 Dec 22;19(1):
pubmed: 35010335

Auteurs

Giulia Savarese (G)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Luna Carpinelli (L)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Anna De Chiara (A)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Claudio Giordano (C)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Matilde Perillo (M)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Domenico Fornino (D)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Francesco De Caro (F)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Mario Capunzo (M)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Giuseppina Moccia (G)

Department of Medicine and Surgery, University of Salerno, Baronissi Campus, 84081 Baronissi, Italy.

Classifications MeSH